Exelixis
EXEL
#1757
Rank
ยฃ9.13 B
Marketcap
ยฃ36.35
Share price
-2.63%
Change (1 day)
14.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company